𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Treatment of stiff-man syndrome with intravenous immune globulin

✍ Scribed by Elizabeth W. Karlson; Lewis Sudarsky; Eric Ruderman; Susan Pierson; Mary Scott; Simon M. Helfgott

Publisher
John Wiley and Sons
Year
1994
Tongue
English
Weight
375 KB
Volume
37
Category
Article
ISSN
0004-3591

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Relapses in the Guillain–Barré syndrome
Relapses in the Guillain–Barré syndrome after treatment with intravenous immune globulin or plasma exchange
✍ J.G. Romano; F.T. Rotta; P. Potter; V. Rosenfeld; R. Santibanez; B. Rocha; W.G. 📂 Article 📅 1998 🏛 John Wiley and Sons 🌐 English ⚖ 72 KB 👁 1 views

To clarify the question of whether Guillain-Barre ´syndrome (GBS) patients treated with intravenous immune globulin (IVIG) relapse at a higher frequency than those treated with plasma exchange (PE), 54 patients with GBS were studied retrospectively. A higher frequency of relapses was noted in the PE

Treatment of Lambert-Eaton syndrome with
Treatment of Lambert-Eaton syndrome with intravenous immunoglobulin
✍ Mark M. Rich; James W. Teener; Shawn J. Bird 📂 Article 📅 1997 🏛 John Wiley and Sons 🌐 English ⚖ 165 KB 👁 1 views

## MUSCLE & NERVE May 1997 improvement is so minimal that it is difficult to detect S: Effect of intravenous immunoglobulin in Lambert-Eaton electrophysiologically. Evaluation of jitter and neuromyasthenic syndrome with small-cell lung cancer: correlation muscular block through single-fiber electr

Treatment of immune-mediated thrombocyto
Treatment of immune-mediated thrombocytopenia purpura with concurrent intravenous immunoglobulin and platelet transfusion: A retrospective review of 40 patients
✍ Joseph E. Spahr; George M. Rodgers 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 131 KB 👁 2 views

## Abstract We performed a retrospective review of patients with immune‐mediated thrombocytopenia (ITP) treated with prolonged infusions of intravenous immunoglobulin (IVIg) (1 g/kg by continuous infusion over 24 hr) and concurrent platelets (1 pheresis unit every 8 hr), to determine the response r